Skip to contentB
Balance Labs, Inc.
B
BLNCBalance Labs, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$117.74K-$117.74KderivedN/M vs Q4 2023 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$64,008N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Balance Labs, Inc. · CIK 1632121 · Engraved from SEC EDGAR
Operating Cash Flowderived-$44,708N/M ended Dec 31, 2024 · filed Apr 15, 2025 · 105 d after period end